COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers Post published:June 3, 2021 Post category:Press Release
Mindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic Medicine Post published:June 3, 2021 Post category:Press Release
Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021 Post published:June 3, 2021 Post category:Press Release
MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research Post published:June 3, 2021 Post category:Press Release
MEC Announces Submission of Listing Statement to the CSE in Coordination with Albert Labs RTO Post published:June 3, 2021 Post category:Press Release
Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick & Mortar Psychedelic and Functional Mushroom Shop in the Western Hemisphere Post published:June 2, 2021 Post category:Press Release
Cybin Announces Sponsorship of a Kernel Flow Feasibility Study to Measure Ketamine’s Psychedelic Effects on Cerebral Cortex Hemodynamics Post published:June 1, 2021 Post category:Press Release
PharmaTher and TSRL Enter into Co-Development Agreement For Microneedle Patch Delivery Technology for Psychedelics and Antivirals Post published:June 1, 2021 Post category:Press Release
Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site Post published:June 1, 2021 Post category:Press Release
MYND Life Sciences announces Depression Biomarker Diagnostic Program Post published:June 1, 2021 Post category:Press Release